Showing results (61-70 of 66) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Journal of Medicinal Chemistry|March 29, 2014
Discovery of selective 4-Amino-pyridopyrimidine inhibitors of MAP4K4 using fragment-based lead identification and optimizationTerry D Crawford, Chudi O Ndubaku, Huifen Chen, et al.Neuromodulation : Journal of the International Neuromodulation Society|May 13, 2024
Randomized Placebo-Controlled Trial of 60-Day Percutaneous Peripheral Nerve Stimulation Treatment Indicates Relief of Persistent Postoperative Pain, and Improved Function After Knee ReplacementJohnathan H Goree, Stuart A Grant, David M Dickerson, et al.ACS Medicinal Chemistry Letters|August 20, 2015
Structure-Based Design of GNE-495, a Potent and Selective MAP4K4 Inhibitor with Efficacy in Retinal AngiogenesisChudi O Ndubaku, Terry D Crawford, Huifen Chen, et al.Journal of Medicinal Chemistry|February 17, 2012
Potent and selective aminopyrimidine-based B-Raf inhibitors with favorable physicochemical and pharmacokinetic propertiesSimon Mathieu, Stefan N Gradl, Li Ren, et al.Pain Medicine (Malden, Mass.)|October 25, 2025
Comparison of Percutaneous 60-Day Peripheral Nerve Stimulation of the Lumbar Medial Branches to Usual Care with Standard Interventional Management for Chronic Low Back Pain-a Multicenter Pragmatic Randomized Controlled Trial (RESET)Zachary L McCormick, Denise D Lester, Michael J DePalma, et al.Interventional Pain Medicine|June 15, 2026
Observations from the RESET clinical trial: A post-hoc per protocol analysis of clinical outcomes with percutaneous 60-day medial branch PNS in chronic low back painSean Li, Zachary L McCormick, Denise D Lester, et al.Pageof 7